Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3196 AL 3210

The role of iron transporters and regulators in Alzheimer's disease and Parkinson's disease: Pathophysiological insights and therapeutic prospects

Tian S, Wang B, Ding Y, Zhang Y, Yu P, Chang YZ, Gao G.

Biomed Pharmacother. 2024 Oct;179:117419. doi: 10.1016/j.biopha.2024.117419. Epub 2024 Sep 8.

Effect of 5-alpha reductase inhibitors in animal models of Parkinson's disease

Bourque M, Morissette M, Isenbrandt A, Giatti S, Melcangi RC, Carta M, Frau R, Bortolato M, Soulet D, Di Paolo T.

Front Neuroendocrinol. 2024 Oct;75:101156. doi: 10.1016/j.yfrne.2024.101156. Epub 2024 Sep 29.

Effects of Tai-Chi on Quality of Life in People With Neurodegenerative Diseases. A systematic Review of Randomised Clinical Trials

Navas-Otero A, Pineda-Nogueras A, Ortiz-Rubio A, Calvache Mateo A, Torres-Sánchez I, Carmen Valenza M, Granados-Santiago M.

Am J Health Promot. 2024 Jul;38(6):873-882. doi: 10.1177/08901171241233095. Epub 2024 Mar 2.

Genomic profile of Parkinson's disease in Asians

Besin V, Humardani FM, Yulianti T, Justyn M.

Clin Chim Acta. 2024 Jan 1;552:117682. doi: 10.1016/j.cca.2023.117682. Epub 2023 Nov 26.

Aquaporin-4 and Parkinson's Disease

Lapshina KV, Ekimova IV.

Int J Mol Sci. 2024 Jan 30;25(3):1672. doi: 10.3390/ijms25031672.

Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease

Soares ÉN, Costa ACDS, Ferrolho GJ, Ureshino RP, Getachew B, Costa SL, da Silva VDA, Tizabi Y.

Cells. 2024 Mar 7;13(6):474. doi: 10.3390/cells13060474.

Association between Parkinson's Disease and Cancer: New Findings and Possible Mediators

Surguchov A, Surguchev AA.

Int J Mol Sci. 2024 Mar 31;25(7):3899. doi: 10.3390/ijms25073899.

Current trends in basic research on Parkinson's disease: from mitochondria, lysosome to α-synuclein

Matsui H, Takahashi R.

J Neural Transm (Vienna). 2024 Jun;131(6):663-674. doi: 10.1007/s00702-024-02774-2. Epub 2024 Apr 13.

Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients

Doskas T, Vadikolias K, Ntoskas K, Vavougios GD, Tsiptsios D, Stamati P, Liampas I, Siokas V, Messinis L, Nasios G, Dardiotis E.

Neurol Int. 2024 Apr 16;16(2):432-449. doi: 10.3390/neurolint16020032.

Treatment of Apathy in Parkinson's Disease and Implications for Underlying Pathophysiology

Maher S, Donlon E, Mullane G, Walsh R, Lynch T, Fearon C.

J Clin Med. 2024 Apr 11;13(8):2216. doi: 10.3390/jcm13082216.

The molecular mechanism of ferroptosis and its relationship with Parkinson's disease

Su Y, Jiao Y, Cai S, Xu Y, Wang Q, Chen X.

Brain Res Bull. 2024 Jul;213:110991. doi: 10.1016/j.brainresbull.2024.110991. Epub 2024 May 31.

Frailty and Parkinson's disease: the role of diabetes mellitus

Komici K, Pansini A, Bencivenga L, Rengo G, Pagano G, Guerra G.

Front Med (Lausanne). 2024 May 30;11:1377975. doi: 10.3389/fmed.2024.1377975. eCollection 2024.

Parkinson's Disease and Mitotherapy-Based Approaches towards α-Synucleinopathies

Bhatt V, Shukla H, Tiwari AK.

J Integr Neurosci. 2024 May 29;23(6):109. doi: 10.31083/j.jin2306109.

Research advancement in fluid biomarkers for Parkinson's disease

Gaetani L, Paolini Paoletti F, Mechelli A, Bellomo G, Parnetti L.

Expert Rev Mol Diagn. 2024 Oct;24(10):885-898. doi: 10.1080/14737159.2024.2403073. Epub 2024 Sep 18.

The zona incerta system: Involvement in Parkinson's disease

Shi Y, Zhang J, Xiu M, Xie R, Liu Y, Xie J, Shi L.

Exp Neurol. 2024 Dec;382:114992. doi: 10.1016/j.expneurol.2024.114992. Epub 2024 Oct 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias